Rechercher des projets européens

4 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

Intelligent materials for in-situ heart Valve tissue engineering (IMAVALVE)

Date du début: 1 janv. 2014, Date de fin: 31 déc. 2017,

In situ tissue engineering using a biodegradable synthetic scaffold that recruits endogenous cells from the bloodstream is emerging as a promising technology to create living heart valves inside the human body having the potential to last a life-time: one valve for life. Compared to classical tissue engineered heart valves this new technology demonstrates off-the-shelf availability at substantiall ...
Voir le projet

 7

 TERMINÉ 

Image-guided pancreatic cancer therapy (iPaCT)

Date du début: 1 janv. 2014, Date de fin: 31 déc. 2017,

The aim of the iPaCT project is to address the unmet clinical need for an improved therapy of pancreatic cancer by developing a new integrated technology platform for image-guided thermal therapy. Yearly, 280000 new cases of pancreatic cancer are diagnosed worldwide. Being usually diagnosed late stage and without any efficient therapy available, basically all patients die with an average life expe ...
Voir le projet

 9

 TERMINÉ 

Bioactive Implantable Polymers based on UreidoPyrimidinone (BIP-UPy)

Date du début: 1 févr. 2013, Date de fin: 31 janv. 2017,

BIP-UPy addresses the need for biomedical implants which can be easily fine-tuned in their properties in regards to bioactivity, biodegradability, and mechanical performance, and thereby be optimized for their targeted clinical application.This project will develop a library comprising of a selection of synthetic polymers and specific bioactivities which can be used to provide the required propert ...
Voir le projet

 11

 TERMINÉ 
The objective of the application is the development and characterization of small molecule stabilizers of protein-protein interactions (“Molecular Glues”) as a novel class of biological tool compounds and potential therapeutic drugs for the treatment of cancer as well as Alzheimer’s and Parkinson’s Disease, respectively. As biological targets we work on 14-3-3 proteins, an important class of adapt ...
Voir le projet

 5